Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
98M
-
Number of holders
-
38
-
Total 13F shares, excl. options
-
19.6M
-
Shares change
-
-904K
-
Total reported value, excl. options
-
$105M
-
Value change
-
-$6.16M
-
Put/Call ratio
-
2.9
-
Number of buys
-
19
-
Number of sells
-
-22
-
Price
-
$5.35
Significant Holders of aTYR PHARMA INC - COMMON STOCK (ATYR) as of Q1 2022
57 filings reported holding ATYR - aTYR PHARMA INC - COMMON STOCK as of Q1 2022.
aTYR PHARMA INC - COMMON STOCK (ATYR) has 38 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.6M shares
of 98M outstanding shares and own 20.03% of the company stock.
Largest 10 shareholders include FEDERATED HERMES, INC. (5.22M shares), FMR LLC (4.17M shares), VR Adviser, LLC (1.4M shares), Tikvah Management LLC (1.35M shares), VANGUARD GROUP INC (1.14M shares), TANG CAPITAL MANAGEMENT LLC (1.11M shares), Deep Track Capital, LP (1.03M shares), Alyeska Investment Group, L.P. (761K shares), BAKER BROS. ADVISORS LP (625K shares), and Stonepine Capital Management, LLC (602K shares).
This table shows the top 38 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.